Acinetobacter baumannii DSM 102930 is a bacterium that has multiple antibiotic resistances and was isolated from human, central venous catheter.
antibiotic resistance Bacteria| @ref 20215 |
|
Last LPSN update
2026-02-09 11:31:30 |
| Domain Bacteria |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Pseudomonadales |
| Family Moraxellaceae |
| Genus Acinetobacter |
| Species Acinetobacter baumannii |
| Full scientific name Acinetobacter baumannii Bouvet and Grimont 1986 |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 23391 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive  | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 23391 | NUTRIENT AGAR (DSMZ Medium 1) | Medium recipe at MediaDive | Name: NUTRIENT AGAR (DSMZ Medium 1) Composition: Agar 15.0 g/l Peptone 5.0 g/l Meat extract 3.0 g/l Distilled water |
| @ref | Growth | Type | Temperature (°C) | |
|---|---|---|---|---|
| 23391 | positive | growth | 30 |
| Test 1 | Test 2 | |
|---|---|---|
| @ref | 23391 | 23391 |
| Medium | Mueller-Hinton Agar | Müller-Hinton Agar |
| Manual annotation | 1 | 1 |
| Inhibition zone diameter in mm | Inhibition zone diameter in mm | |
| Amikacin 30µg (disc) | 0 | 0 |
| Ampicillin 10µg (disc) | 0 | 0 |
| Aztreonam 30µg (disc) | 10 | 8 |
| Bacitracin 10Unit | 6 | n.d. |
| Cefalotin 30µg (disc) | 0 | n.d. |
| Cefazolin 30µg (disc) | 0 | n.d. |
| Cefiderocol 30µg (disc) | n.d. | 20-22 |
| Cefotaxime 30µg (disc) | 0 | 0 |
| Ceftazidime 10µg (disc) | n.d. | 0 |
| Ceftriaxone 30µg (disc) | 0 | 0 |
| Chloramphenicol 30µg (disc) | 0 | 0 |
| Ciprofloxacin 5µg (disc) | n.d. | 20 |
| Clindamycin 10µg (disc) | 0 | 0 |
| Colistin 10µg (disc) | 16-18 | n.d. |
| Colistin sulphate 10µg (disc) | n.d. | 18 |
| Doxycycline 30µg (disc) | 8 | n.d. |
| Erythromycin 15µg (disc) | 12 | 12 |
| Fosfomycin 50µg (disc) | 10 | 8 |
| Gentamicin 30µg (disc) | n.d. | 0 |
| Gentamycin 10µg (disc) | n.d. | |
| Imipenem 10µg (disc) | 8 | 6 |
| Kanamycin 30µg (disc) | 0 | 0 |
| Levofloxacin 5µg (disc) | n.d. | 22-24 |
| Lincomycin 15µg (disc) | 0 | n.d. |
| Linezolid 10µg (disc) | 0 | 0 |
| Meropenem 10µg (disc) | n.d. | 8-10 |
| Mezlocillin 30µg (disc) | 0 | n.d. |
| Moxifloxacin 5µg (disc) | 24 | 26 |
| Neomycin 30µg (disc) | 8 | n.d. |
| Nitrofurantoin 100µg (disc) | 10 | 0 |
| Norfloxacin 10µg (disc) | 8 | n.d. |
| Nystatin 100Unit | 0 | n.d. |
| Ofloxacin 5µg (disc) | 16-18 | 18 |
| Oxacillin 5µg (disc) | 0 | 0 |
| Penicillin G 6µg (disc) | 0 | 0 |
| Pipemidic acid 20µg (disc) | 0 | n.d. |
| Piperacillin/Tazobactam 40µg (disc) | 12 | n.d. |
| Piperacillin/Tazobactam 110µg (disc) | n.d. | 12 |
| Polymyxin B 300Unit | 18 | 20 |
| Quinupristin/Dalfopristin 15µg (disc) | 0 | 0 |
| Rifampicin 5µg (disc) | n.d. | 18 |
| Teicoplanin 30µg (disc) | 0 | 0 |
| Tetracycline 30µg (disc) | 0 | 0 |
| Ticarcillin 75µg (disc) | 0 | 0 |
| Tigecycline 15µg (disc) | n.d. | 20 |
| Trimethoprim-sulfamethoxazole (1:19) 10µg (disc) | n.d. | 0 |
| Vancomycin 30µg (disc) | 0 | 0 |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68369 | 17128 ChEBI | adipate | + | assimilation | from API 20NE |
| 68369 | 29016 ChEBI | arginine | - | hydrolysis | from API 20NE |
| 68369 | 17634 ChEBI | D-glucose | + | assimilation | from API 20NE |
| 68369 | 17634 ChEBI | D-glucose | - | fermentation | from API 20NE |
| 68369 | 27689 ChEBI | decanoate | + | assimilation | from API 20NE |
| 68369 | 4853 ChEBI | esculin | - | hydrolysis | from API 20NE |
| 68369 | 5291 ChEBI | gelatin | - | hydrolysis | from API 20NE |
| 68369 | 24265 ChEBI | gluconate | + | assimilation | from API 20NE |
| 68369 | 30849 ChEBI | L-arabinose | + | assimilation | from API 20NE |
| 68369 | 25115 ChEBI | malate | + | assimilation | from API 20NE |
| 68369 | 17632 ChEBI | nitrate | - | reduction | from API 20NE |
| 68369 | 27897 ChEBI | tryptophan | - | energy source | from API 20NE |
| 68369 | 16199 ChEBI | urea | - | hydrolysis | from API 20NE |
| @ref | ChEBI | Metabolite | Is resistant | Resistance conc. | |
|---|---|---|---|---|---|
| 23391 | 2637 | Amikacin | 30 µg (disc) | from Antibiotic test | |
| 23391 | 28971 | Ampicillin | 10 µg (disc) | from Antibiotic test | |
| 23391 | 124991 | Cefalotin | 30 µg (disc) | from Antibiotic test | |
| 23391 | 474053 | Cefazolin | 30 µg (disc) | from Antibiotic test | |
| 23391 | 204928 | Cefotaxime | 30 µg (disc) | from Antibiotic test | |
| 23391 | 3508 | Ceftazidime | 10 µg (disc) | from Antibiotic test | |
| 23391 | 29007 | Ceftriaxone | 30 µg (disc) | from Antibiotic test | |
| 23391 | 17698 | Chloramphenicol | 30 µg (disc) | from Antibiotic test | |
| 23391 | 3745 | Clindamycin | 10 µg (disc) | from Antibiotic test | |
| 23391 | 17833 | Gentamicin | 30 µg (disc) | from Antibiotic test | |
| 23391 | 17833 | Gentamycin | 10 µg (disc) | from Antibiotic test | |
| 23391 | 6104 | Kanamycin | 30 µg (disc) | from Antibiotic test | |
| 23391 | 6472 | Lincomycin | 15 µg (disc) | from Antibiotic test | |
| 23391 | 63607 | Linezolid | 10 µg (disc) | from Antibiotic test | |
| 23391 | 6919 | Mezlocillin | 30 µg (disc) | from Antibiotic test | |
| 23391 | 7660 | Nystatin | 100 Unit | from Antibiotic test | |
| 23391 | 7809 | Oxacillin | 5 µg (disc) | from Antibiotic test | |
| 23391 | 18208 | Penicillin G | 6 µg (disc) | from Antibiotic test | |
| 23391 | 75250 | Pipemidic acid | 20 µg (disc) | from Antibiotic test | |
| 23391 | Quinupristin/Dalfopristin | 15 µg (disc) | from Antibiotic test | ||
| 23391 | 29687 | Teicoplanin | 30 µg (disc) | from Antibiotic test | |
| 23391 | 27902 | Tetracycline | 30 µg (disc) | from Antibiotic test | |
| 23391 | 9587 | Ticarcillin | 75 µg (disc) | from Antibiotic test | |
| 23391 | Trimethoprim-sulfamethoxazole (1:19) | 10 µg (disc) | from Antibiotic test | ||
| 23391 | 28001 | Vancomycin | 30 µg (disc) | from Antibiotic test |
| Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|
| Microbiome-derived antimicrobial peptides show therapeutic activity against the critically important priority pathogen, Acinetobacter baumannii. | Alexander PJ, Oyama LB, Olleik H, Godoy Santos F, O'Brien S, Cookson A, Cochrane SA, Gilmore BF, Maresca M, Huws SA. | NPJ Biofilms Microbiomes | 10.1038/s41522-024-00560-2 | 2024 | |
| An Application of Imipenem Discs or P. aeruginosa ATCC 27853 Reference Strain Increases Sensitivity of Carbapenem Inactivation Method for Non-Fermenting Gram-Negative Bacteria. | Bogiel T, Rzepka M, Gospodarek-Komkowska E. | Antibiotics (Basel) | 10.3390/antibiotics10070875 | 2021 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive131595.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License